Praxis Precision Medicines Stock Drops After Culper Research Reveals Short Position
The firm alleged that Praxis “gamed” the data from its late-stage trial of Ulixacaltamide in essential tremor.
Stocktwits·18m ago
More News
PACS Group Stock Soars Premarket On Completion Of Audit Committee Probe, Upbeat Full-Year Guidance
The company said the committee's recommendations have been or are being implemented.
Stocktwits·3h ago
Atkore Expands Review Process: CEO To Stay On As It Explores Sale Or Merger Options
Bill Waltz noted that, given the board’s decision to expand the strategic alternatives process, he has decided to stay on as CEO.
Stocktwits·6h ago
AGIO Stock Cracks After Sickle-Cell Disease Drug Delivers Mixed Results In Late-Stage Trial
Sickle cell disease is an inherited blood disorder where red blood cells become rigid, sickle-shaped, and unable to flow easily through blood vessels, causing pain and organ damage.
Stocktwits·1d ago
Joby Aviation To Launch Electric Air Taxi Test Flights In Saudi Arabia
The company said that under the agreement, Joby will work together with Red Sea Global and The Helicopter Company to establish a "sandbox" for pre-commercial operations.
Stocktwits·1d ago
Archer Aviation Lands Partnership To Deploy Air Taxi In Saudi Arabia
The partnership will focus on the development, testing, and potential integration of Archer’s eVTOL aircraft into RSG’s operations.
Stocktwits·1d ago
Why Did Scholar Rock Soar 26% Today?
The company is planning to reapply for approval of a muscle atrophy therapy in the coming year.
Stocktwits·6d ago
Topgolf Callaway Brands Jumps 5% After Report Says Talks Are On To Sell Topgolf Unit
According to a report by The Wall Street Journal, citing people familiar with the matter, the deal would value Topgolf at about $1 billion.
Stocktwits·6d ago
Merck To Buy Cidara In $9.2B Deal To Strengthen Antiviral Portfolio
With the new deal, Merck would gain access to CD388, currently in late-stage development, and designed to prevent influenza infection in individuals at higher risk of influenza complications.
Stocktwits·6d ago
AVXL Shares Slump Pre-Market After EMA Committee Fails To Recommend Approval For Alzheimer’s Drug
The CHMP released its meeting highlights on Friday and recommended approval for ten new medicines, but Blarcamesine was not included in the list.
